CVE-2017-3844

Description

A vulnerability in exporting functions of the user interface for Cisco Prime Collaboration Assurance could allow an authenticated, remote attacker to view file directory listings and download files. Affected Products: Cisco Prime Collaboration Assurance software versions 11.0, 11.1, and 11.5 are vulnerable. Cisco Prime Collaboration Assurance software versions prior to 11.0 are not vulnerable. More Information: CSCvc86238. Known Affected Releases: 11.5(0).

Category

4.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.20%
Vendor Advisory cisco.com
Affected: n/a Cisco Prime Collaboration Assurance
Published at:
Updated at:

References

Link Tags
https://tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-20170215-pcp2 vendor advisory
http://www.securityfocus.com/bid/96247 vdb entry
http://www.securitytracker.com/id/1037843 vdb entry

Frequently Asked Questions

What is the severity of CVE-2017-3844?
CVE-2017-3844 has been scored as a medium severity vulnerability.
How to fix CVE-2017-3844?
To fix CVE-2017-3844, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-3844 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-3844 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-3844?
CVE-2017-3844 affects n/a Cisco Prime Collaboration Assurance.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.